116 results
8-K
EX-10.1
EYPT
EyePoint Pharmaceuticals Inc
10 Jul 23
EyePoint Pharmaceuticals Announces Chief Executive Officer Transition
7:05am
8-K
EX-10.2
EYPT
EyePoint Pharmaceuticals Inc
10 Jul 23
EyePoint Pharmaceuticals Announces Chief Executive Officer Transition
7:05am
8-K
EX-10.1
zp2ds 283qxb2l7g0w22
21 Jun 23
Departure of Directors or Certain Officers
7:53am
8-K
EX-10.1
0p2r7 hwg
18 May 23
EyePoint Pharmaceuticals Announces Sale of YUTIQ® to Alimera Sciences, Inc. for $82.5 Million Cash Plus Royalties
7:06am
8-K
EX-10.4
e6veiursjkrro5zbsqr
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.1
3n7j7w65d 2ppaqyvp
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.3
79s1xjxevh
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.2
3p966 79cp5
6 Jan 23
EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines
5:03pm
8-K
EX-10.1
hnimlbo3o8aqfjql4
14 Nov 22
Departure of Directors or Certain Officers
8:30am